Trading Signals: REGN Stock Price Prediction and Forecast (Fri. Mar. 14, 2014 - Fri. Dec. 22, 2023)(Regeneron Pharmaceuticals Inc)
| REGN latest price $512.8900 (2.22%) ($501.7600 - $515.0000) on Wed. Jun. 17, 2015. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 12.53% (three month average) | RSI | 9 | Latest Price | $512.8900(2.22%) | Stocks Behave Similarly | Similar Stock List | Weekly Trend | REGN declines -0.1% a week on average for past two weeks. | Market Behavior | Normal for large cap. Normal for small cap. | Correlated ETFs | Broad market will support REGN advance at 0% a week (0% probability) IBB(47%) XLV(37%) XBI(36%) QQQ(31%) SPY(29%) | Factors Impacting REGN price | REGN will decline at least -6.265% in a week (0% probabilities). VIXM(-12%) TLT(-6%) UUP(-3%) SHY(-2%) IGOV(-2%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -6.265% (StdDev 12.53%) | Hourly BBV | 0 () | Intraday Trend | 2.2% | | | |
|
5 Day Moving Average | $501.42(2.29%) | 10 Day Moving Average | $461.47(11.14%) | 20 Day Moving Average | $485.32(5.68%) | To recent high | -4.9% | To recent low | 17% | Market Cap | $54.381b | | | | Regeneron Pharmaceuticals, Inc. is a biotechnology company, which engages in the discovery, invention, development, manufacture, and commercialization of medicines. It product portfolio includes the following brands: EYLEA, Dupixent, Praluent, Kevzara, Libtayo, ARCALYST, and ZALTRAP. The company was founded by Alferd G. Gilman, Leonard S. Schleifer, and Eric M. Shooter on January 8, 1988 and is headquartered in Tarrytown, NY. |